The European Medicines Agency (EMA) gave the green light, on Friday 28 May for the use of the Covid-19 vaccine developed by Pfizer/BioNTech for young people aged 12 to 15 years.
The Comirnaty vaccine can therefore be given to adolescents as it is currently given to people aged 16 and over, in the form of two injections three weeks apart, says EMA.
The efficacy of Comirnaty was calculated in almost 2,000 young people who were given the vaccine or a placebo. “Of the 1,005 children receiving...